Journal of Gastroenterology and Digestive Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Opinion Article - Journal of Gastroenterology and Digestive Diseases (2022) Volume 7, Issue 5

Clinical experience with the use of stomach, ileum, and colon for augmentation cystoplasty.

Traditionally, augmentation cytoplast (AC) has been used to treat low capacity, inadequately compliant, or recalcitrant overactive bladder (OAB). In detrusor over activity, the use of intravenous botulinum toxin and sacral neuromodulator has reduced the number of AC procedures performed. However, AC is still useful in paediatric and renal transplant settings, and it is still a feasible treatment choice for refractory OAB. Laparoscopic and robotic augmentation cytoplast has been developed thanks to advancements in surgical technique. Although ileocystoplasty is the most common treatment, a number of intestinal segments can be employed. Thromboembolism and death are common early consequences, although metabolic disturbances, bacteriuria, urinary tract stones, incontinence, perforation, the requirement for intermittent self-catheterization, and cancer are common long-term issues. The current indications are examined in this article

Author(s): Chyou Autumn

Abstract Full Text PDF

Get the App